Dicerna Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch DRNA and buy or sell other stocks, options, and ETFs commission-free!

About DRNA

Dicerna Pharmaceuticals is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, along with cancers, and other therapeutic areas to address liver problems. It is using ribonucleic acid interference (RNA) technology platform to develop its products.

CEO

Douglas M. Fambrough, III, PhD

CEODouglas M. Fambrough, III, PhD

Employees

—

Employees—

Headquarters

Lexington, Massachusetts

HeadquartersLexington, Massachusetts

Founded

2006

Founded2006

Employees

—

Employees—

DRNA Key Statistics

Market cap

2.98B

Market cap2.98B

Price-Earnings ratio

-23.44

Price-Earnings ratio-23.44

Dividend yield

—

Dividend yield—

Average volume

3.20M

Average volume3.20M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$40.14

52 Week high$40.14

52 Week low

$19.06

52 Week low$19.06